Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%) Cipla informs about press release
Date: 09-04-2020Cipla has informed that the company has enclosed press release dated 9th April 2020 regarding ’Cipla receives final approval for generic version of Proventil HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation)’.
The above information is a part of company’s filings submitted to BSE.